Filing Details
- Accession Number:
- 0001209191-17-022762
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-03-24 16:24:10
- Reporting Period:
- 2017-03-23
- Filing Date:
- 2017-03-24
- Accepted Time:
- 2017-03-24 16:24:10
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1419600 | Flexion Therapeutics Inc | FLXN | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1129890 | W Frederick Driscoll | C/O Flexion Therapeutics, Inc. 10 Mall Road, Suite 301 Burlington MA 01803 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-03-23 | 3,000 | $7.89 | 10,777 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-03-23 | 3,000 | $23.00 | 7,777 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock option (right to buy) | Disposition | 2017-03-23 | 3,000 | $0.00 | 3,000 | $7.89 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
102,300 | 2023-05-19 | No | 4 | M | Direct |
Footnotes
- Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted December 20, 2016.
- 1/4 of the shares subject to the option vest one year after May 20, 2013, with 1/48th of the shares vesting monthly thereafter over the next 3 years.